原始单价和二价新冠疫苗对未免疫功能低下的孕妇新冠相关急诊科和紧急护理就诊的有效性：VISION网络，2022年6月至2023年8月
Effectiveness of the Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters in Pregnant Persons Who Were Not Immunocompromised: VISION Network, June 2022-August 2023.
作者信息
Avrich Ciesla Allison, Lazariu Victoria, Dascomb Kristin, Irving Stephanie A, Dixon Brian E, Gaglani Manjusha, Naleway Allison L, Grannis Shaun J, Ball Sarah, Kharbanda Anupam B, Vazquez-Benitez Gabriela, Klein Nicola P, Natarajan Karthik, Ong Toan C, Embi Peter J, Fleming-Dutra Katherine E, Link-Gelles Ruth, Zerbo Ousseny
机构信息
Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Eagle Health Analytics, San Antonio, Texas, USA.
出版信息
Open Forum Infect Dis. 2024 Aug 28;11(9):ofae481. doi: 10.1093/ofid/ofae481. eCollection 2024 Sep.
Abstract
Pregnant people face increased risk of severe COVID-19. Current guidelines recommend updated COVID-19 vaccination (2023-2024) for those aged ≥6 months, irrespective of pregnancy status. To refine recommendations for pregnant people, further data are needed. Using a test-negative design, we evaluated COVID-19 vaccine effectiveness against medically attended COVID-19 with COVID-19-like illness among pregnant people aged 18 to 45 years during June 2022 to August 2023. When doses were received during pregnancy, vaccine effectiveness was 52% (95% CI, 29%-67%); when received <6 months prior to pregnancy, 28% (95% CI, 11%-42%); and when received ≥6 months prior to pregnancy, 6% (95% CI, -11% to 21%). Pregnant people should stay up-to-date with recommended COVID-19 vaccination.
摘要
孕妇面临患重症 COVID-19 的风险增加。当前指南建议为年龄≥6 个月的人群接种更新的 COVID-19 疫苗（2023 - 2024 年），无论其妊娠状态如何。为完善针对孕妇的建议，还需要更多数据。我们采用检测阴性设计，评估了 2022 年 6 月至 2023 年 8 月期间 18 至 45 岁孕妇中 COVID-19 疫苗对因 COVID-19 样疾病就医的 COVID-19 的有效性。孕期接种疫苗时，疫苗有效性为 52%（95%置信区间，29% - 67%）；孕前<6 个月接种时，为 28%（95%置信区间，11% - 42%）；孕前≥6 个月接种时，为 6%（95%置信区间，-11%至 21%）。孕妇应及时接种推荐的 COVID-19 疫苗。
相似文献
1
Effectiveness of the Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters in Pregnant Persons Who Were Not Immunocompromised: VISION Network, June 2022-August 2023.原始单价和二价新冠疫苗对未免疫功能低下的孕妇新冠相关急诊科和紧急护理就诊的有效性：VISION网络，2022年6月至2023年8月
Open Forum Infect Dis. 2024 Aug 28;11(9):ofae481. doi: 10.1093/ofid/ofae481. eCollection 2024 Sep.
2
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.2022 年 9 月至 11 月，免疫功能正常的成年人中，二价 mRNA 疫苗在预防 COVID-19 相关急诊或紧急护理就诊和住院方面的早期效果估计 - VISION 网络，九个州。
MMWR Morb Mortal Wkly Rep. 2022 Dec 30;71(5152):1616-1624. doi: 10.15585/mmwr.mm715152e1.
3
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.2022 年 9 月至 11 月，免疫功能正常成年人中，二价 mRNA 疫苗在预防 COVID-19 相关急诊或紧急护理就诊和住院方面的早期效果估计- VISION 网络，9 个州。
MMWR Morb Mortal Wkly Rep. 2023 Mar 17;71(53):1637-1646. doi: 10.15585/mmwr.mm7153a1.
4
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023.单价和双价 mRNA 疫苗在预防 6 月龄-5 岁儿童因 COVID-19 前往急诊科和紧急护理的有效性 - VISION 网络，美国，2022 年 7 月至 2023 年 6 月。
MMWR Morb Mortal Wkly Rep. 2023 Aug 18;72(33):886-892. doi: 10.15585/mmwr.mm7233a2.
5
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States.美国 Delta 和奥密克戎变异株流行期间估计 COVID-19 mRNA 疫苗在孕妇中对有医疗需要的 COVID-19 的有效性。
JAMA Netw Open. 2022 Sep 1;5(9):e2233273. doi: 10.1001/jamanetworkopen.2022.33273.
6
Effectiveness of BNT162b2 BA.4/5 bivalent mRNA vaccine against a range of COVID-19 outcomes in a large health system in the USA: a test-negative case-control study.BNT162b2 BA.4/5 二价 mRNA 疫苗在美国大型医疗体系中针对一系列 COVID-19 结局的有效性：一项病例对照研究。
Lancet Respir Med. 2023 Dec;11(12):1089-1100. doi: 10.1016/S2213-2600(23)00306-5. Epub 2023 Oct 25.
7
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022.COVID-19 mRNA 疫苗在奥密克戎为主导期间对免疫功能低下成年人 COVID-19 相关住院的有效性- VISION 网络，10 个州，2021 年 12 月至 2022 年 8 月。
MMWR Morb Mortal Wkly Rep. 2022 Oct 21;71(42):1335-1342. doi: 10.15585/mmwr.mm7142a4.
8
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.在德尔塔和奥密克戎变异株流行期间，mRNA 疫苗加强针在成年人中的 COVID-19 相关急诊和紧急护理就诊和住院方面的效果 - VISION 网络，10 个州，2021 年 8 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 21;71(4):139-145. doi: 10.15585/mmwr.mm7104e3.
9
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.mRNA 疫苗对 COVID-19 相关急诊科和紧急护理就诊以及成人住院的 2 剂和 3 剂效力下降在德尔塔和奥密克戎变异主导期间 - VISION 网络，10 个州，2021 年 8 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Feb 18;71(7):255-263. doi: 10.15585/mmwr.mm7107e2.
10
Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021.COVID-19 疫苗在预防免疫功能低下成年人急诊或紧急护理就诊和住院方面的有效性：2021 年 8 月至 12 月期间在美国 10 个州的真实世界数据的观察性研究。
Vaccine. 2023 Aug 23;41(37):5424-5434. doi: 10.1016/j.vaccine.2023.05.038. Epub 2023 May 22.
本文引用的文献
1
Effectiveness of Maternal mRNA COVID-19 Vaccination During Pregnancy Against COVID-19-Associated Hospitalizations in Infants Aged <6 Months During SARS-CoV-2 Omicron Predominance - 20 States, March 9, 2022-May 31, 2023.母亲在怀孕期间接种 mRNA COVID-19 疫苗对 2022 年 3 月 9 日至 2023 年 5 月 31 日期间，在 SARS-CoV-2 奥密克戎流行期间 6 月龄以下婴儿因 COVID-19 相关住院的有效性-20 个州。
MMWR Morb Mortal Wkly Rep. 2023 Sep 29;72(39):1057-1064. doi: 10.15585/mmwr.mm7239a3.
2
Effectiveness of COVID-19 vaccination during pregnancy by circulating viral variant.孕期接种新冠疫苗针对循环病毒变体的有效性。
AJOG Glob Rep. 2023 Aug 25;3(4):100264. doi: 10.1016/j.xagr.2023.100264. eCollection 2023 Nov.
3
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023.临床流行病学和接种与未接种 COVID-19 住院成年人重症结局的危险因素-VISION 网络，10 个州，2021 年 6 月至 2023 年 3 月。
Clin Infect Dis. 2024 Feb 17;78(2):338-348. doi: 10.1093/cid/ciad505.
4
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023.2022 年 9 月至 2023 年 4 月，在有和无免疫功能低下情况的成年人中，二价 mRNA 疫苗预防 COVID-19 相关住院和重症的持久性估计 - VISION 网络。
MMWR Morb Mortal Wkly Rep. 2023 May 26;72(21):579-588. doi: 10.15585/mmwr.mm7221a3.
5
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.2022 年 9 月至 11 月，免疫功能正常成年人中，二价 mRNA 疫苗在预防 COVID-19 相关急诊或紧急护理就诊和住院方面的早期效果估计- VISION 网络，9 个州。
MMWR Morb Mortal Wkly Rep. 2023 Mar 17;71(53):1637-1646. doi: 10.15585/mmwr.mm7153a1.
6
Effectiveness of a third BNT162b2 mRNA COVID-19 vaccination during pregnancy: a national observational study in Israel.孕期接种第三剂 BNT162b2 mRNA COVID-19 疫苗的有效性：以色列的一项全国性观察性研究。
Nat Commun. 2022 Nov 15;13(1):6961. doi: 10.1038/s41467-022-34605-x.
7
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States.美国 Delta 和奥密克戎变异株流行期间估计 COVID-19 mRNA 疫苗在孕妇中对有医疗需要的 COVID-19 的有效性。
JAMA Netw Open. 2022 Sep 1;5(9):e2233273. doi: 10.1001/jamanetworkopen.2022.33273.
8
The effect of maternal SARS-CoV-2 infection timing on birth outcomes: a retrospective multicentre cohort study.母亲感染 SARS-CoV-2 时间对出生结局的影响：一项回顾性多中心队列研究。
Lancet Digit Health. 2022 Feb;4(2):e95-e104. doi: 10.1016/S2589-7500(21)00250-8. Epub 2022 Jan 13.
9
Systematic review and meta-analysis of COVID-19 maternal and neonatal clinical features and pregnancy outcomes up to June 3, 2021.截至2021年6月3日新型冠状病毒肺炎孕产妇及新生儿临床特征与妊娠结局的系统评价和荟萃分析
AJOG Glob Rep. 2022 Feb;2(1):100049. doi: 10.1016/j.xagr.2021.100049. Epub 2022 Jan 3.
10
Zotero 插件